Lu‐Yu Zhou

6.5k total citations · 3 hit papers
57 papers, 5.1k citations indexed

About

Lu‐Yu Zhou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lu‐Yu Zhou has authored 57 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 26 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Lu‐Yu Zhou's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (12 papers). Lu‐Yu Zhou is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (12 papers) and RNA modifications and cancer (12 papers). Lu‐Yu Zhou collaborates with scholars based in China, United States and Philippines. Lu‐Yu Zhou's co-authors include Cui-Yun Liu, Peifeng Li, Kun Wang, Bo Long, Fang Liu, Teng Sun, Yanhan Dong, Jianxun Wang, Man Wang and Ying Gong and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Lu‐Yu Zhou

53 papers receiving 5.0k citations

Hit Papers

A circular RNA protects the heart from pathological hyper... 2014 2026 2018 2022 2016 2014 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu‐Yu Zhou China 32 3.7k 3.1k 500 490 405 57 5.1k
Yong He China 38 2.7k 0.7× 2.0k 0.6× 1.4k 2.9× 134 0.3× 685 1.7× 104 5.2k
Shun Liu China 27 5.9k 1.6× 4.7k 1.5× 214 0.4× 78 0.2× 287 0.7× 92 7.1k
Hua Zhong China 22 2.6k 0.7× 2.6k 0.8× 210 0.4× 85 0.2× 424 1.0× 73 5.0k
Bo Qu China 35 2.0k 0.5× 1.5k 0.5× 209 0.4× 97 0.2× 746 1.8× 120 3.8k
Lei Tian China 36 2.3k 0.6× 600 0.2× 171 0.3× 416 0.8× 520 1.3× 102 3.6k
Yanbin Zhang China 40 3.5k 0.9× 1.3k 0.4× 187 0.4× 81 0.2× 356 0.9× 191 5.0k
Gang An China 30 1.7k 0.4× 524 0.2× 158 0.3× 160 0.3× 408 1.0× 273 3.7k
Xiaojing Wang China 33 1.9k 0.5× 424 0.1× 445 0.9× 130 0.3× 237 0.6× 149 3.6k
Yuwei Li China 33 1.3k 0.4× 537 0.2× 126 0.3× 146 0.3× 378 0.9× 191 3.5k

Countries citing papers authored by Lu‐Yu Zhou

Since Specialization
Citations

This map shows the geographic impact of Lu‐Yu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Yu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Yu Zhou more than expected).

Fields of papers citing papers by Lu‐Yu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu‐Yu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Yu Zhou. The network helps show where Lu‐Yu Zhou may publish in the future.

Co-authorship network of co-authors of Lu‐Yu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Yu Zhou. A scholar is included among the top collaborators of Lu‐Yu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Yu Zhou. Lu‐Yu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tao, Xinzhe Chen, Hongfei Xu, et al.. (2025). MCPPIR promotes cardiomyocyte proliferation and cardiac repair via o8G oxidation of POC1B mRNA. Cardiovascular Research. 122(2). 270–284.
2.
Zhou, Lu‐Yu, Sixiang Liu, Guolong Wu, et al.. (2025). Ultrafast photocatalytic degradation enabled by atomically dispersed Ag on BiOIO 3 nanosheets: unraveling synergistic photo-thermal-ferroelectric effects. Journal of Materials Chemistry A. 13(36). 30576–30586.
3.
Zhao, Yan, Kai Wang, Chun Zhao, et al.. (2024). The function of tRNA-derived small RNAs in cardiovascular diseases. Molecular Therapy — Nucleic Acids. 35(1). 102114–102114. 8 indexed citations
4.
Ju, Jie, Kai Wang, Fang Liu, et al.. (2024). Crotonylation of NAE1 Modulates Cardiac Hypertrophy via Gelsolin Neddylation. Circulation Research. 135(8). 806–821. 9 indexed citations
5.
Zhou, Lu‐Yu, et al.. (2023). Improved LSTM-based deep learning model for COVID-19 prediction using optimized approach. Engineering Applications of Artificial Intelligence. 122. 106157–106157. 40 indexed citations
6.
Tan, Wenjun, et al.. (2023). A new segment method for pulmonary artery and vein. Health Information Science and Systems. 11(1). 47–47. 2 indexed citations
7.
Wang, Kai, Fuhai Li, Lu‐Yu Zhou, et al.. (2023). HNEAP Regulates Necroptosis of Cardiomyocytes by Suppressing the m5C Methylation of Atf7 mRNA. Advanced Science. 10(34). e2304329–e2304329. 19 indexed citations
8.
Zhou, Lu‐Yu, et al.. (2023). Optimization of mammalian expression vector by cis-regulatory element combinations. Molecular Genetics and Genomics. 298(5). 1121–1133. 2 indexed citations
9.
Wang, Kai, Xinzhe Chen, Yunhong Wang, et al.. (2022). Emerging roles of ferroptosis in cardiovascular diseases. Cell Death Discovery. 8(1). 394–394. 77 indexed citations
10.
Wang, Kai, Tao Wang, Xiangqian Gao, et al.. (2021). Emerging functions of piwi‐interacting RNAs in diseases. Journal of Cellular and Molecular Medicine. 25(11). 4893–4901. 21 indexed citations
11.
Wang, Kai, Xiangqian Gao, Tao Wang, & Lu‐Yu Zhou. (2021). The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases. Cardiovascular Drugs and Therapy. 37(1). 181–198. 24 indexed citations
12.
Gao, Xiangqian, Cui-Yun Liu, Yuhui Zhang, et al.. (2021). The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death and Differentiation. 29(3). 527–539. 63 indexed citations
13.
Wang, Kai, Yanhan Dong, Jing Liu, et al.. (2020). Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 24 indexed citations
14.
Dai, Liang, Honglei Wang, Lu‐Yu Zhou, et al.. (2017). Regional and local new particle formation events observed in the Yangtze River Delta region, China. Journal of Geophysical Research Atmospheres. 122(4). 2389–2402. 50 indexed citations
15.
Wang, Kun, Lu‐Yu Zhou, Jianxun Wang, et al.. (2015). E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Nature Communications. 6(1). 7619–7619. 88 indexed citations
16.
Wang, Kai, Bo Long, Tao An, et al.. (2015). NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1. Cell Death and Disease. 6(12). e2007–e2007. 49 indexed citations
17.
Wang, Kai, Tao An, Lu‐Yu Zhou, et al.. (2014). E2F1-regulated miR-30b suppresses Cyclophilin D and protects heart from ischemia/reperfusion injury and necrotic cell death. Cell Death and Differentiation. 22(5). 743–754. 58 indexed citations
18.
Wang, Kai, Fang Liu, Lu‐Yu Zhou, et al.. (2013). miR-874 regulates myocardial necrosis by targeting caspase-8. Cell Death and Disease. 4(7). e709–e709. 99 indexed citations
19.
Zhou, Lu‐Yu, et al.. (2012). Mitochondrial function in cardiac hypertrophy. International Journal of Cardiology. 167(4). 1118–1125. 33 indexed citations
20.
Zhou, Lu‐Yu, Y. Wang, Wei Xia, et al.. (2007). Identification and characterization of a MBP isoform specific to hypothalamus in orange-spotted grouper (Epinephelus coioides). Journal of Chemical Neuroanatomy. 34(1-2). 47–59. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026